Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

By Mourad Yasser   Taher Ali   Chehal Aref   Shamseddine Ali  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 319-321

Springer Publishing Company

Access to resources Recommend Favorite

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

By Gemmel C.   Cremer F.   Weis M.   Witzens M.   Moldenhauer G.   Koniczek K.-H.   Imbach U.   Ho A.   Moos M.   Goldschmidt H.  

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine

By Bernasconi Paolo   Paulli Marco   Orlandi Ester   Perfetti Vittorio   Giardini Ilaria   Zibellini Silvia   Vanelli Laura   Tenore Anna   Algarotti Alessandra   Boni Marina   Amici Mara   Brusamolino Ercole   Lazzarino Mario  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 619-622

Springer Publishing Company

Access to resources Recommend Favorite

Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)

By Gonzalez-Stawinski G.V.   Yu P.B.   Love S.D.   Parker W.   Davis R.D.  

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 175-179

Academic Press

Access to resources Recommend Favorite

Anti-CD3 induces splenic B220 lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization

By Todo Tsuyoshi   Wu Gordon   Chai Ning-ning   He Yao   Martins Gislaine   Gupta Ankur   Fair Jeffrey   Liu Nai-you   Jordan Stanley   Klein Andrew  

International Immunology, Vol. 24, Iss. 8, 2012-08 ,pp. : 529-538

Oxford University Press

Access to resources Recommend Favorite